US Map / Oregon
State OR

Clinical Trials in Oregon

Oregon is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Oregon and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 195 actively recruiting studies with Oregon sites out of 195 registered in total. The busiest research areas in Oregon are Breast Cancer, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Oregon Health and Science University, National Cancer Institute (NCI), VA Office of Research and Development. By stage, Oregon trials break down as Phase 1 (25), Phase 2 (49), Phase 3 (55), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
195
Recruiting Now
195
← Back to US Map
Top Conditions in Oregon
Breast Cancer (7)Endometrial Cancer (6)Advanced Solid Tumor (5)Ovarian Cancer (4)Colorectal Cancer (4)Multiple Myeloma (4)Metastatic Solid Tumor (3)Cancer (3)Lung Cancer (3)Prostate Cancer (3)Thyroid Cancer (3)NSCLC (Non-small Cell Lung Cancer) (3)

Frequently Asked Questions — Clinical Trials in Oregon

How many clinical trials are currently recruiting in Oregon?
ClinicalMetric currently tracks 195 actively recruiting clinical trials with at least one location in Oregon. The total number of registered studies—including active but not currently enrolling trials—is 195. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Oregon?
Oregon hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Oregon serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Oregon?
To join a clinical trial in Oregon, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Oregon maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Oregon

NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
View Trial →
NCT05080946 EARLY_Phase 1
Recruiting
Using Aspirin to Improve Immunological Features of Ovarian Tumors
Condition
Ovarian Cancer
Enrollment
100 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT07244263 Phase 2
Recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa
Enrollment
90 pts
Location
United States, Australia, Canada
Sponsor
Takeda
View Trial →
NCT05660031 N/A
Recruiting
Treatment of the Biceps With Concomitant Supraspinatus Tears
Condition
Supraspinatus Tear
Enrollment
180 pts
Location
United States, Canada, Switzerland
Sponsor
La Tour Hospital
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06375551 N/A
Recruiting
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interven...
Condition
Child Abuse
Enrollment
80 pts
Location
United States
Sponsor
Chestnut Health Systems
View Trial →
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
View Trial →
NCT06779773 N/A
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice ...
Condition
Geographic Atrophy
Enrollment
500 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06577987 Phase 1
Recruiting
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignanc...
Condition
Advanced Solid Tumor
Enrollment
220 pts
Location
United States
Sponsor
Circle Pharma
View Trial →
NCT04389632 Phase 1
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Condition
Carcinoma, Non-Small Cell Lung
Enrollment
1,006 pts
Location
United States, France, South Korea
Sponsor
Seagen, a wholly owned subsidi
View Trial →
NCT04743271 N/A
Recruiting
Food and Circadian Timing
Condition
Diet, High-Fat
Enrollment
14 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT04671667 Phase 2
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itse...
Condition
Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment
188 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06175000 Phase 2
Recruiting
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lympho...
Condition
Primary Central Nervous System Lymphoma
Enrollment
28 pts
Location
United States
Sponsor
Providence Health & Services
View Trial →
NCT05366881 N/A
Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and ...
Condition
Brain Cancer
Enrollment
7,000 pts
Location
United States
Sponsor
Adela, Inc
View Trial →
NCT06891794 N/A
Recruiting
Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Pri...
Condition
IUD
Enrollment
24 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT06563895 Phase 3
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) S...
Condition
Amyloidosis
Enrollment
587 pts
Location
United States, Argentina, Australia
Sponsor
Eidos Therapeutics, a BridgeBi
View Trial →
NCT06312722 N/A
Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market S...
Condition
Benign Prostatic Hyperplasia
Enrollment
92 pts
Location
United States
Sponsor
Urotronic Inc.
View Trial →
NCT05919329 Phase 4
Recruiting
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Ho...
Condition
Castration Resistant Prostate Cancer
Enrollment
80 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
View Trial →
NCT07391657 Phase 3
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antig...
Condition
Relapsed Refractory Multiple Myeloma
Enrollment
508 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
View Trial →
NCT03578003 N/A
Recruiting
Morning Bright Light to Improve Sleep Quality in Veterans
Condition
Brain Injuries, Traumatic
Enrollment
200 pts
Location
United States
Sponsor
Portland VA Medical Center
View Trial →
NCT06911424 Phase 3
Recruiting
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Condition
Bacterial Conjunctivitis
Enrollment
400 pts
Location
United States
Sponsor
Baxis Pharmaceuticals, Inc.
View Trial →
NCT04986423 Phase 2
Recruiting
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castrat...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
200 pts
Location
United States, China
Sponsor
Zenith Epigenetics
View Trial →
NCT05873686 Phase 1
Recruiting
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Condition
Advanced Solid Tumor
Enrollment
140 pts
Location
United States, United Kingdom
Sponsor
Nuvectis Pharma, Inc.
View Trial →
NCT05775627 N/A
Recruiting
Sleep and Metabolism
Condition
Sleep Deprivation
Enrollment
20 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
Page 1 of 8 — 195 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology